Login to Your Account


Avoiding the PCSK9 frenzy with alternative drug targets

By Brian Orelli
Contributing Writer

Monday, March 17, 2014

PCSK9 is a hot target for lowering cholesterol with Amgen Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Pfizer Inc. and many other companies developing drugs to inhibit the protein.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription